VIDEX

Absence of Clinically Relevant Drug Interactions Following Simultaneous Administration of Didanosine-encapsulated, Enteric-coated Bead Formulation with Either Itraconazole or Fluconazole
PRAVACOL
Pravastatin Reduces Restenosis Two
Years After Percutaneous Transluminal
Coronary Angioplasty (REGRESS Trial)
Pravastatin and the Development of Diabetes Mellitus
Safety and Tolerability of Pravastatin in Long Term Clinical Trials: Pravastatin Pooling Project
Marc A. Pfeffer
Effect of Statin Therapy on C-Reactive
Protein Levels
ZERIT
Guidelines for Using Antiretroviral Agents
Among HIV-Infected Adults and Adolescents
Nucleoside-Analogue Reverse-Transcriptase
Inhibitors Plus Nevirapine, Nelfinavir,
or Ritonavir for Pretreated Children Infected
with Human Immunodeficiency Virus Type 1
Guidelines for the Use of Antiretroviral Agents in
Pediatric HIV Infection

PEDIATRIC ANTIRETROVIRAL DRUG INFORMATION
Recommendations for Use of Antiretroviral
Drugs in Pregnant HIV-1-Infected Women
for Maternal Health and
Interventions to Reduce Perinatal HIV-1
Transmission in the United States
Pharmacokinetics of Stavudine and Didanosine Coadministered with Nelfinavir in Human Immunodeficiency Virus-Exposed Neonates
Economic Evaluation of Drug Resistance Genotyping for the
Adaptation of Treatment in HIV-Infected Patients in the
VIRADAPT Study
D rug-resistance genotyping in HIV-1 t h e r a p y: the VIRAD A P T
randomised controlled trial
A Rapid Method for Simultaneous Detection of Phenotypic
Resistance to Inhibitors of Protease and Reverse Transcriptase
in Recombinant Human Immunodeficiency Virus Type 1
Isolates from Patients Treated with Antiretroviral Drugs
Stavudine, nevirapine and ritonavir in stable antiretroviral therapy-experienced chidren with human immunodeficiency virus infection
Sexually Transmitted Diseases
Treatment Guidelines
2002
Nucleoside-Analogue Reverse-Transcriptase
Inhibitors Plus Nevirapine, Nelfinavir,
or Ritonavir for Pretreated Children Infected
with Human Immunodeficiency Virus Type 1